The content on this site is intended for healthcare professionals only
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
How to avoid malpractice in breast imaging
Breast intervention workshops at BGICC 2023
Tomosynthesis guided biopsy
Overview of the management of HER2-low breast cancer patients
Differential diagnosis of lesions with radiation structure
Updates on HER2-low breast cancer
BGICC 2023: Breast contouring workshop
FLASH-radiation therapy: hype or game changer?
Lymph node irradiation therapy for BC in the 21st Century
The young female breast: case review
Features of inflammatory breast cancer and triple negative breast cancer
Evidence-based approach to lymph node assessment and targeted axillary dissection
Novel antibody-drug conjugates (ADCs) technologies for management of mBC
The role of lymph nodes in stage 3 lung cancer
Pregnancy after breast cancer
Developments in surgery for early stage lung cancer
The role of multidisciplinary tumour board in managing stage 3 lung cancer
Breast cancer challenges in Africa: Role of Pan African Cancer Alliance
COMMENT: Women Who Conquer Cancer
The advancements in radiotherapy for breast cancer patients
Loco-regional management after neoadjuvant chemotherapy
Surgical management of Axilla: Past, present and future
Updates in management of B3 breast lesion
Cancer pain management
Spindle cell lesions of the breast
Developments in breast reconstructive surgery
Moving to the future: Artificial intelligence in surgery
Comment: Artificial Intelligence and surgical management of Axilla
Imaging advances for breast surgery
Women Who Conquer Cancer
Stereotactic body radiotherapy with CyberKnife in adrenal and spinal tumours
Management of HER2 positive metastatic breast cancer treatment algorithm
Indications of radiotherapy after mastectomy
Optimising breast cancer treatments with AI
Immuno-radiotherapy: rationale and new perspectives for breast cancer patients
Oligometastatic breast cancer: old to new entity, outcome and treatment algorithm
Updates in the diagnostic criteria of serous tubal intraepithelial carcinoma
Globular neoplasia and invasive lobular BC pathology and multiple variables of special types of breast cancers
Personalised risk-stratified breast cancer screening for BRCA germline mutations and other genes
Post neoadjuvant management in BRCA mutant breast cancer patients
